| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 9, Issue 2 147-154, Copyright © 1998 by American Association of Cancer Research
ARTICLES |
Y Cho, MG Klein and DA Talmage
Institute of Human Nutrition, Columbia University, New York, New York 10032, USA.
As F9 embryonal carcinoma cells differentiate into parietal endoderm-like cells, expression of conventional protein kinase C (PKC) changes. Undifferentiated stem cells express PKCbeta but not PKCalpha, whereas differentiated parietal endoderm cells express PKCalpha but not PKCbeta. To determine whether changes in PKCalpha and/or PKCbeta expression control retinoic acid (RA)- and dibutyryl cyclic AMP-induced F9 cell differentiation, we established cell lines stably expressing PKCalpha, PKCbeta, antisense PKCalpha, or antisense PKCbeta RNAs. Constitutive expression of PKCalpha or inhibition of PKCbeta expression in F9 stem cells enhanced RA induced differentiation, both by increasing total expression and accelerating RA-induced expression of laminins A, B1, B2, and type IV collagen. In addition, expressing PKCbeta in a parietal endoderm cell line caused these cells to retrodifferentiate into stem cells. Based on these results, we conclude that PKCbeta and PKCalpha are key targets for RA-regulated gene expression, that PKCalpha plays an important, active role in inducing and maintaining the parietal endoderm phenotype, and that PKCbeta activity is incompatible with maintaining the differentiated state of these cells.
This article has been cited by other articles:
![]() |
Y. Chen, M. L. Hancock, L. W. Role, and D. A. Talmage Intramembranous Valine Linked to Schizophrenia Is Required for Neuregulin 1 Regulation of the Morphological Development of Cortical Neurons J. Neurosci., July 7, 2010; 30(27): 9199 - 9208. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamasaki, A. Takahashi, J. Pan, N. Yamaguchi, and K. K. Yokoyama Phosphorylation of Activation Transcription Factor-2 at Serine 121 by Protein Kinase C Controls c-Jun-mediated Activation of Transcription J. Biol. Chem., March 27, 2009; 284(13): 8567 - 8581. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pasquali, P. Chieffi, W. J Deery, G. Nicoletti, A. Bellastella, and A. A Sinisi Differential effects of all-trans-retinoic acid (RA) on Erk1/2 phosphorylation and cAMP accumulation in normal and malignant human prostate epithelial cells: Erk1/2 inhibition restores RA-induced decrease of cell growth in malignant prostate cells Eur. J. Endocrinol., April 1, 2005; 152(4): 663 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, L. J. Zhang, A. Farhadi, J. Z. Fields, M. Shaikh, C. B. Forsyth, S. Choudhary, and A. Keshavarzian Critical Role of the Atypical {lambda} Isoform of Protein Kinase C (PKC-{lambda}) in Oxidant-Induced Disruption of the Microtubule Cytoskeleton and Barrier Function of Intestinal Epithelium J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 458 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, L.J. Zhang, M. Shaikh, J.Z. Fields, A. Farhadi, and A. Keshavarzian {theta}-Isoform of PKC is required for alterations in cytoskeletal dynamics and barrier permeability in intestinal epithelium: a novel function for PKC-{theta} Am J Physiol Cell Physiol, July 1, 2004; 287(1): C218 - C234. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, L. J. Zhang, A. Farhadi, J. Z. Fields, M. Shaikh, and A. Keshavarzian PKC-{beta}1 isoform activation is required for EGF-induced NF-{kappa}B inactivation and I{kappa}B{alpha} stabilization and protection of F-actin assembly and barrier function in enterocyte monolayers Am J Physiol Cell Physiol, March 1, 2004; 286(3): C723 - C738. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, J. Z. Fields, L. J. Zhang, M. Shaikh, A. Farhadi, and A. Keshavarzian {zeta} Isoform of Protein Kinase C Prevents Oxidant-Induced Nuclear Factor-{kappa}B Activation and I-{kappa}B{alpha} Degradation: A Fundamental Mechanism for Epidermal Growth Factor Protection of the Microtubule Cytoskeleton and Intestinal Barrier Integrity J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 53 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, A. Farhadi, J. Z. Fields, L. J. Zhang, M. Shaikh, and A. Keshavarzian The delta -Isoform of Protein Kinase C Causes Inducible Nitric-Oxide Synthase and Nitric Oxide Up-Regulation: Key Mechanism for Oxidant-Induced Carbonylation, Nitration, and Disassembly of the Microtubule Cytoskeleton and Hyperpermeability of Barrier of Intestinal Epithelia J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 482 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, J. Z. Fields, A. Farhadi, D. A. Talmage, L. Zhang, and A. Keshavarzian Activation of delta -Isoform of Protein Kinase C Is Required for Oxidant-Induced Disruption of Both the Microtubule Cytoskeleton and Permeability Barrier of Intestinal Epithelia J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 17 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, L. Zhang, J. Z. Fields, A. Farhadi, D. A. Talmage, and A. Keshavarzian PKC-zeta prevents oxidant-induced iNOS upregulation and protects the microtubules and gut barrier integrity Am J Physiol Gastrointest Liver Physiol, October 1, 2002; 283(4): G909 - G922. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, J. Z. Fields, A. Farhadi, D. A. Talmage, L. Zhang, and A. Keshavarzian The beta 1 Isoform of Protein Kinase C Mediates the Protective Effects of Epidermal Growth Factor on the Dynamic Assembly of F-Actin Cytoskeleton and Normalization of Calcium Homeostasis in Human Colonic Cells J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 852 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, J. Z. Fields, D. A. Talmage, Y. Zhang, and A. Keshavarzian PKC-{beta}1 mediates EGF protection of microtubules and barrier of intestinal monolayers against oxidants Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G833 - G847. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, J. Z. Fields, D. A. Talmage, L. Zhang, and A. Keshavarzian PKC-zeta is required in EGF protection of microtubules and intestinal barrier integrity against oxidant injury Am J Physiol Gastrointest Liver Physiol, May 1, 2002; 282(5): G794 - G808. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |